LU92209I2 - Clevidipine sous toutes les formes procurant une protection à partir du brevet de base - Google Patents

Clevidipine sous toutes les formes procurant une protection à partir du brevet de base

Info

Publication number
LU92209I2
LU92209I2 LU92209C LU92209C LU92209I2 LU 92209 I2 LU92209 I2 LU 92209I2 LU 92209 C LU92209 C LU 92209C LU 92209 C LU92209 C LU 92209C LU 92209 I2 LU92209 I2 LU 92209I2
Authority
LU
Luxembourg
Prior art keywords
hydrogen
pct
chloro
methyl
clevidipine
Prior art date
Application number
LU92209C
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of LU92209I2 publication Critical patent/LU92209I2/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
LU92209C 1993-11-05 2013-06-10 Clevidipine sous toutes les formes procurant une protection à partir du brevet de base LU92209I2 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9303657A SE9303657D0 (sv) 1993-11-05 1993-11-05 Short-acting dihydropyridines

Publications (1)

Publication Number Publication Date
LU92209I2 true LU92209I2 (fr) 2013-08-23

Family

ID=20391655

Family Applications (1)

Application Number Title Priority Date Filing Date
LU92209C LU92209I2 (fr) 1993-11-05 2013-06-10 Clevidipine sous toutes les formes procurant une protection à partir du brevet de base

Country Status (36)

Country Link
US (1) US5856346A (fr)
EP (1) EP0726894B1 (fr)
JP (1) JP3712209B2 (fr)
KR (1) KR100331663B1 (fr)
CN (1) CN1049428C (fr)
AT (1) ATE194330T1 (fr)
AU (1) AU685532B2 (fr)
BR (1) BR9407946A (fr)
CA (1) CA2174969C (fr)
CZ (1) CZ285691B6 (fr)
DE (1) DE69425152T2 (fr)
DK (1) DK0726894T3 (fr)
EE (1) EE03230B1 (fr)
EG (1) EG20539A (fr)
ES (1) ES2150544T3 (fr)
FI (1) FI110429B (fr)
FR (1) FR12C0053I2 (fr)
GR (1) GR3034469T3 (fr)
HK (1) HK1013292A1 (fr)
HU (1) HU215591B (fr)
IL (1) IL111127A (fr)
IS (1) IS1674B (fr)
LU (1) LU92209I2 (fr)
MY (1) MY111770A (fr)
NO (1) NO305656B1 (fr)
NZ (1) NZ275915A (fr)
PL (1) PL185099B1 (fr)
PT (1) PT726894E (fr)
RU (1) RU2139278C1 (fr)
SA (1) SA94150250B1 (fr)
SE (1) SE9303657D0 (fr)
SK (1) SK281467B6 (fr)
TW (1) TW279859B (fr)
UA (1) UA45959C2 (fr)
WO (1) WO1995012578A1 (fr)
ZA (1) ZA947570B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9804002D0 (sv) * 1998-11-23 1998-11-23 Astra Ab New manufacturing process
WO2003059193A2 (fr) * 2001-12-21 2003-07-24 Alcon, Inc. Utilisation de nanoparticules en tant qu'excipients pour biocides dans des compositions ophtalmiques
FR2922439B1 (fr) * 2007-10-18 2010-12-10 Hill Rom Ind Sa Procede de gonflage alterne d'un dispositif de support a cellules gonflables et dispositif pour sa mise en oeuvre
BRPI0916936B8 (pt) 2008-08-01 2021-05-25 Chiesi Farm Spa composições farmacêuticas, uso de clevidipina e método de reduzir impurezas.
ES2543470T3 (es) * 2009-09-30 2015-08-19 Microdose Therapeutx, Inc. Métodos y composiciones para el tratamiento del fenómeno de Raynaud
CN101780036B (zh) * 2010-03-30 2011-11-16 武汉武药科技有限公司 丁酸氯维地平脂微球注射液及其制备方法
CA2701087A1 (fr) * 2010-04-12 2011-10-12 Alphora Research Inc. Preparation de butyrate de clevidipine
US8455655B2 (en) 2010-05-07 2013-06-04 Laboratorios Lesvi, S.L. Preparation of dihydropyridines
EP2386544B1 (fr) 2010-05-07 2016-02-10 Laboratorios Lesvi, S.L. Préparation of dihydropyridines
US8658676B2 (en) 2010-10-12 2014-02-25 The Medicines Company Clevidipine emulsion formulations containing antimicrobial agents
MX2013004151A (es) 2010-10-12 2013-05-20 Medicines Co Formulaciones de emulsion de clevidipina que contienen agentes antimicrobianos.
JP2014509654A (ja) * 2011-04-01 2014-04-21 ザ メディシンズ カンパニー 脳卒中損傷の低減に使用するための短時間作用型ジヒドロピリジン（クレビジピン）
CN103906508A (zh) 2011-08-26 2014-07-02 沃克哈特有限公司 治疗心血管疾病的方法
CN103420899B (zh) * 2012-05-25 2016-01-27 四川科伦药物研究有限公司 一种丁酸氯维地平的纯化方法
CN110840890A (zh) 2012-10-26 2020-02-28 凯西制药公司 用于在心力衰竭中控制血压和减轻呼吸困难的方法
CN103073485B (zh) * 2013-01-17 2015-09-02 北京嘉林药业股份有限公司 一种丁酸氯维地平的制备方法
CN103086956B (zh) * 2013-01-17 2015-11-04 北京嘉林药业股份有限公司 一种丁酸氯维地平中间体的纯化方法
CN106456617A (zh) 2014-05-19 2017-02-22 医药公司 氯维地平纳米颗粒及其药物组合物
CN105367487A (zh) * 2014-08-23 2016-03-02 南京海纳医药科技有限公司 一种丁酸氯维地平重要中间体新的合成方法
CN104370802A (zh) * 2014-09-24 2015-02-25 北京蓝丹医药科技有限公司 氯维地平衍生物及其制备方法
JP7045191B2 (ja) 2015-05-20 2022-03-31 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド 駆虫性デプシペプチド化合物
JP6943859B2 (ja) 2015-12-28 2021-10-06 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド 駆虫性デプシペプチド化合物
JP2020504710A (ja) 2016-11-16 2020-02-13 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド 駆虫性デプシペプチド化合物
RU2755349C1 (ru) * 2021-02-16 2021-09-15 Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Применение бензил 6-({ 2-[(3,4-диметилфенил)амино]-2-оксоэтил} тио)-2-метил-4-(4-хлорфенил)-5-циано-1,4-дигидропиридин-3-карбоксилата в качестве гепатопротекторного средства

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
US4154839A (en) * 1975-11-05 1979-05-15 Bayer Aktiengesellschaft 2,6-Dimethyl-3-carboxymethoxy-4-(2-nitrophenyl)-5-carbisobutoxy-1,4-dihydropyridine
DE2847236A1 (de) * 1978-10-31 1980-05-14 Bayer Ag Neue dihydropyridine mit substituierten estergruppierungen, mehrer verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
KR940003492B1 (ko) * 1988-10-27 1994-04-23 주식회사 유한양행 1,4-디하이드로피리딘유도체 및 그의 제조방법
US5134139A (en) * 1989-08-31 1992-07-28 Tanabe Seiyaku Co., Ltd. 1,5-benzothiazepine derivatives and preparation thereof
JPH0641075A (ja) * 1990-09-01 1994-02-15 Kazuo Achinami 新規な１，４−ジヒドロピリジン化合物及びその製造方法

Also Published As

Publication number Publication date
FR12C0053I1 (fr) 2012-02-11
IS4218A (is) 1995-05-06
AU685532B2 (en) 1998-01-22
DK0726894T3 (da) 2000-10-23
SE9303657D0 (sv) 1993-11-05
EG20539A (en) 1999-07-31
AU8119694A (en) 1995-05-23
ES2150544T3 (es) 2000-12-01
EE03230B1 (et) 1999-10-15
DE69425152D1 (de) 2000-08-10
NO961776D0 (no) 1996-05-02
MY111770A (en) 2000-12-30
RU2139278C1 (ru) 1999-10-10
FI961914A0 (fi) 1996-05-06
SK55996A3 (en) 1996-12-04
US5856346A (en) 1999-01-05
ATE194330T1 (de) 2000-07-15
NO305656B1 (no) 1999-07-05
CZ285691B6 (cs) 1999-10-13
PT726894E (pt) 2000-10-31
CZ127396A3 (en) 1996-09-11
JPH09504542A (ja) 1997-05-06
SK281467B6 (sk) 2001-04-09
PL185099B1 (pl) 2003-02-28
HU215591B (hu) 1999-01-28
IL111127A0 (en) 1994-12-29
GR3034469T3 (en) 2000-12-29
EP0726894B1 (fr) 2000-07-05
DE69425152T2 (de) 2001-03-22
NO961776L (no) 1996-05-02
JP3712209B2 (ja) 2005-11-02
FR12C0053I2 (fr) 2013-08-16
FI961914A (fi) 1996-05-06
HK1013292A1 (en) 1999-08-20
HU9601187D0 (en) 1996-07-29
HUT75316A (en) 1997-05-28
EP0726894A1 (fr) 1996-08-21
BR9407946A (pt) 1996-11-26
IS1674B (is) 1997-12-31
UA45959C2 (uk) 2002-05-15
TW279859B (fr) 1996-07-01
PL314128A1 (en) 1996-08-19
CN1049428C (zh) 2000-02-16
NZ275915A (en) 1997-04-24
WO1995012578A1 (fr) 1995-05-11
CN1137269A (zh) 1996-12-04
FI110429B (fi) 2003-01-31
IL111127A (en) 2000-11-21
ZA947570B (en) 1995-05-29
SA94150250B1 (ar) 2006-03-01
CA2174969A1 (fr) 1995-05-11
KR100331663B1 (ko) 2002-09-26
CA2174969C (fr) 2005-05-17

Similar Documents

Publication Publication Date Title
LU92209I2 (fr) Clevidipine sous toutes les formes procurant une protection à partir du brevet de base
DK0533280T3 (da) Ny medicinsk anvendelse af tachykininantagonister
RU93004675A (ru) 1,2,4-оксадиазолил-феноксиалкилизоксазолы, их применение в качестве противовирусных агентов, фармацевтическая композиция
ATE88468T1 (de) Arylalkoxycumarine, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel.
RU2218334C2 (ru) Замещенные 1,2,3,4,5,6-гексагидро-2,6-метано-3-бензазоцин-10-олы и фармацевтическая композиция на их основе
ES8307742A1 (es) "un procedimiento para preparar derivados de benzamida".
ES2104370T3 (es) Derivados de (arilalquilaminobencil)aminopropionamidas sustituidas, su preparacion y utilizacion.
TR200000154T2 (tr) 2,4,4-Trisübstitüe-1,3-Dioksolan mantar önleyiciler.
SE9401965D0 (sv) New compounds